$SVFC - Receives US Patent for its Stem Cell Extraction

New Post Public Reply Private Reply Replies (0) Message Board
2TellDeTroot

$SVFC - Receives US Patent for its Stem Cell Extraction Technology

NEW YORK, June 13, 2013 /PRNewswire via COMTEX/ -- IntelliCell BioSciences, Inc. ("Company") (SVFC) announces that it has been notified by the US Patent office that its patent for stem cell extraction technology has been published. IntelliCell's proprietary patented method for deriving blood vessel originated vascular cells from adipose (fat) tissue by use of ultrasonic cavitation has been made official. This technology involves an innovative mechanical method for the separation of stromal vascular fraction cells from adipose (fat) tissue, without the use of enzymes. Vascular cells derived by IntelliCell's proprietary method are potentially useful in bringing the promise of regenerative medicine to many therapeutic and aesthetic procedures. Investors can access the published patent at the US Patent website by entering the patent # 8,440,440. Link to patent website: http://patft.uspto.gov/netahtml/PTO/srchnum.htm
IntelliCell's Chairman and CEO, Dr. Steven Victor, stated "Our Company is very pleased to announce today that with the publishing of our patent, our technology is now protected and we expect our international patent publication in a short time."

About IntelliCell BioSciences, Inc.

IntelliCell BioSciences is a Regenerative Medicine company developing novel technologies that address the regenerative, curative and preventative conditions of disease states with high unmet clinical needs. The Company has several patent-pending applications including the patent that was recently published, an industry unique method of obtaining autologous stromal vascular fraction cells (SVF) cells from the vasculature surrounding adipose tissue containing adult stem cells and a robust population of regenerative healing cells. The Company is also pioneering the development of autologous and allogeneic cells from living and non-living tissue donors for research purposes. IntelliCell is planning a series of in-human clinical studies with top tier universities for the treatment of osteoarthritis, multiple sclerosis, lower limb ischemic wounds, and gum regeneration in the oral cavity as well as medical aesthetics. The Company has developed a first in class cGTP cellular processing facility in New York City, purpose built and designed to be fully integrated into an ambulatory surgery center.

Forward-Looking Statements

Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "will reach," "will change," "will soon," "should," "could," "would," "may," "can" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.

Contacts:Anna Rhodes, IntelliCell BioSciences, Inc. Phone: (646) 576-8710 Email: arhodes@intellicellbiosciences.com

Melissa Diaz, South Street Media, Inc. Phone: (917) 937-8968 Email: info@southstreetmedia.com

SOURCE IntelliCell BioSciences, Inc.

http://rt.prnewswire.com/rt.gif?NewsItemId=NE...d=20130613

www.prnewswire.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vertiv's SmartIT: The New AI Infrastructure Game-Changer

Updated Category News Views 80

Taking AI Infrastructure Up a Notch Vertiv Holdings Co. (NYSE: VRT) is charging ahead with a solution that's bound to rattle the cages of status quo infrastructure deployments. Say hello to Vertiv™ SmartIT, a finely-tuned piece of kit that's pre-engineered to ease up the often painful process of high-density AI deployments across various environments—from homey...

Continue Reading
Custom Concrete: Crafting the Perfect Poolside Paradise

Updated Category News Views 34

Concrete: The Unsung Hero of Your Pool's Success You know, everyone always raves about that sparkling pool, but let's be real—it's the concrete holding the whole gig together. James White from White's Pools in Loganville, GA, drops some knowledge in a recent HelloNation piece about the unsung hero of backyard oases: custom concrete. Yeah, it's not sexy, but when you're...

Continue Reading
Better Home & Finance Faces 28.5% Stock Plunge, Lawsuit

Updated Category News Views 108

The Sudden Dive in Better Home's Stock Imagine cruising down the highway with the wind in your hair and suddenly slamming into a pothole. That's the kind of jarring experience Better Home & Finance Holding Company (NASDAQ: BETR) investors felt when the stock took a nosedive, diving a hefty 28.5%. Back on May 7, 2026, the company released financial figures that flipped the...

Continue Reading
Cumberland Pharmaceuticals Eyes NDA for Ifetroban in DMD

Updated Category News Views 44

Rolling the Dice with Ifetroban There's a buzz in the air around Cumberland Pharmaceuticals as they gear up to tackle one of medicine's stubborn giants, Duchenne muscular dystrophy (DMD). They plan to file a New Drug Application (NDA) with the FDA for ifetroban, aiming to treat the cardiomyopathy plaguing many DMD sufferers. Folks who’ve watched Cumberland (NASDAQ:CPIX)...

Continue Reading
Federal Law Shifts Landscape for Manufactured Housing

Updated Category News Views 93

Federal Act Aims to Boost Manufactured Homes Price tags on homes need a reality check, and for a long time, manufactured housing has been in the corner looking for a chance to throw its hat in the ring. Enter the 21st Century ROAD to Housing Act, aiming to finally unlock the potential sitting in our backyards when it comes to these factory-built options. We're talking...

Continue Reading
Gildan Activewear Faces Major Class Action Lawsuit

Updated Category News Views 151

Investors Turn Against Gildan Activewear Ever see a freight train barreling down the track? That's what it feels like when a class action lawsuit rears its head against a behemoth like Gildan Activewear Inc. (NYSE: GIL). After years of allegedly pulling the wool over investors' eyes, those same investors are now being called to muster—their chance to lead a charge of...

Continue Reading
Temu Partners with Recyclia to Drive EPR Compliance Boost

Updated Category News Views 182

Temu and Recyclia: Building a Sustainable Marketplace Get this: Temu, the e-commerce giant you've heard trumpeting about affordable goods like some digital bazaar, is diving deeper into sustainability waters with a partner that knows a thing or two about waste. This time, they've linked up with Recyclia over in Spain. The duo's focus? Helping marketplace sellers meet the...

Continue Reading
3TREES Debuts Green Coatings to East African Market

Updated Category News Views 0

3TREES Rocks East Africa's Construction Scene Nairobi's got a spark this week, and it's radiating straight from 3TREES' corner at the Big 5 Construct Kenya. With the Sarit Expo Centre buzzing from October 21, 2026, this Chinese company didn't just show up—they made one hell of an entrance. Presenting eco-friendly coating solutions, they pushed the 'Create Healthy Life'...

Continue Reading
Superteam Wheels Rides Into Spain with RACEIT Deal

Updated Category News Views 151

Rolling Out the Red Carpet for Spanish Cyclists Think of it as the pedal-powered bridge from wherever Superteam Wheels calls home to the sunny streets of Spain. If you're in the cycling game, this new partnership between Superteam Wheels and COMERTECH RACEIT, S.L., better known as RACEIT, is drawing a line in the sand—or perhaps on the asphalt—across Europe. Starting...

Continue Reading
Sintilimab Poised for New Milestone in Melanoma Fight

Updated Category News Views 188

An Opening Shot: NMPA's Decision Window Well, here's the latest chapter in the saga of battling advanced melanoma with some real gritty numbers behind it. Innovent Biologics has thrown its hat back in the ring with news that the China National Medical Products Administration (NMPA) has embraced a new indication application for their drug sintilimab. They're teaming it up...

Continue Reading

Top 5 Most Recently Viewed Articles

Alphyn Biologics: Zabalafin Hydrogel Hits Phase 2—What's Next?

Updated Category News Views 167

Alphyn Biologics launched its Phase 2 clinical trial for Zabalafin Hydrogel (ZH) on February 18, 2026. This is no small fry; we’re talking about tackling molluscum contagiosum (MC), a viral skin infection that plagues kids. Parents are already feeling the pinch of managing this highly contagious condition that spreads like wildfire and leaves unsightly bumps on their...

Continue Reading
Limited Time 50% Off Subscription: Empowering Technology Insights

Updated Category News Views 177

Unlock Your Access to Essential Technology Insights For those passionate about understanding the rapidly evolving technological landscape, MIT Technology Review presents an exciting opportunity. With their new, limited-time offer of 50% off an annual subscription, readers are invited to delve deep into the stories and innovations shaping our lives. What You Will Discover...

Continue Reading
Hilton Hotel Workers Demand Fair Wages and Work Conditions

Updated Category News Views 289

Hilton Hotel Workers Stage Strikes in Seattle In a significant move for labor rights, more than a hundred workers at Hilton hotels in Seattle have taken to the streets, demanding better wages and improved working conditions. The Unite Here union, which represents hospitality workers, organized the strike to address several pressing issues affecting its members. Reasons...

Continue Reading
Nüspace Marks a Year of Success with Special Anniversary Event

Updated Category News Views 56

Celebrating Nüspace's Successful Anniversary at Quartier DIX30 Nüspace, a prominent Canadian retailer in contemporary furniture, recently celebrated the first anniversary of its store located at Quartier DIX30. This notable event is a wonderful opportunity not only to commemorate a successful year but also to engage with valued customers and connect with the design...

Continue Reading
Thermal Containment Market Growth Projections and Trends

Updated Category News Views 106

Understanding the Thermal Containment Market Growth The global thermal containment market is predicted to see significant growth, expected to climb from USD 6.6 billion to USD 14.8 billion by 2033. This growth translates into a notable CAGR of 9.4%. The rise in demand for efficient cooling systems is driving this market expansion worldwide. What is Thermal Containment?...

Continue Reading